Ancora Advisors LLC grew its stake in Amrize Ltd (NYSE:AMRZ - Free Report) by 22.9% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 283,522 shares of the company's stock after purchasing an additional 52,759 shares during the quarter. Ancora Advisors LLC owned approximately 0.05% of Amrize worth $15,112,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also modified their holdings of the company. Norges Bank acquired a new stake in Amrize in the 4th quarter valued at about $929,333,000. Wellington Management Group LLP increased its holdings in shares of Amrize by 48.8% in the third quarter. Wellington Management Group LLP now owns 11,622,024 shares of the company's stock valued at $561,018,000 after purchasing an additional 3,809,133 shares during the last quarter. Harris Associates L P acquired a new stake in shares of Amrize in the fourth quarter valued at approximately $615,406,000. Zurcher Kantonalbank Zurich Cantonalbank lifted its position in Amrize by 4.6% during the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 9,518,018 shares of the company's stock worth $459,242,000 after buying an additional 420,728 shares in the last quarter. Finally, Geode Capital Management LLC lifted its position in Amrize by 3.4% during the fourth quarter. Geode Capital Management LLC now owns 6,093,012 shares of the company's stock worth $328,080,000 after buying an additional 198,810 shares in the last quarter.
Analyst Ratings Changes
AMRZ has been the subject of several analyst reports. Oppenheimer dropped their target price on Amrize from $68.00 to $65.00 and set an "outperform" rating for the company in a report on Tuesday, July 21st. Citigroup lowered their price target on shares of Amrize from $66.00 to $58.00 and set a "buy" rating on the stock in a research report on Tuesday, August 11th. Morgan Stanley set a $63.00 price objective on shares of Amrize and gave the company an "overweight" rating in a report on Monday, June 22nd. Deutsche Bank Aktiengesellschaft restated a "buy" rating on shares of Amrize in a research report on Friday, June 26th. Finally, DA Davidson began coverage on shares of Amrize in a research note on Monday, August 24th. They set a "neutral" rating and a $50.00 target price on the stock. One equities research analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating, six have assigned a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average price target of $59.87.
View Our Latest Report on Amrize
Insider Transactions at Amrize
In other news, Director Jacques Wolf Sanche purchased 4,150 shares of the stock in a transaction dated Wednesday, August 26th. The stock was acquired at an average cost of $45.02 per share, for a total transaction of $186,833.00. Following the completion of the transaction, the director directly owned 9,766 shares in the company, valued at approximately $439,665.32. This represents a 73.90% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Mario Gross acquired 3,568 shares of the business's stock in a transaction that occurred on Tuesday, August 11th. The stock was purchased at an average price of $46.60 per share, for a total transaction of $166,268.80. Following the acquisition, the insider directly owned 38,485 shares in the company, valued at approximately $1,793,401. This trade represents a 10.22% increase in their position. The SEC filing for this purchase provides additional information. In the last 90 days, insiders acquired 18,983 shares of company stock worth $884,535. 0.54% of the stock is owned by company insiders.
Amrize Price Performance
NYSE:AMRZ opened at $43.73 on Tuesday. Amrize Ltd has a 52 week low of $43.67 and a 52 week high of $65.94. The stock's fifty day moving average is $49.31 and its two-hundred day moving average is $53.63. The company has a market capitalization of $24.19 billion, a P/E ratio of 20.15, a P/E/G ratio of 0.99 and a beta of 0.12. The company has a quick ratio of 0.73, a current ratio of 1.10 and a debt-to-equity ratio of 0.33.
Amrize (NYSE:AMRZ - Get Free Report) last released its quarterly earnings results on Thursday, August 6th. The company reported $0.88 earnings per share for the quarter, missing analysts' consensus estimates of $0.92 by ($0.04). The business had revenue of $3.49 billion for the quarter. Amrize had a return on equity of 10.22% and a net margin of 9.89%. Equities analysts expect that Amrize Ltd will post 2.74 EPS for the current year.
Amrize Dividend Announcement
The business also recently declared a dividend, which was paid on Wednesday, August 26th. Stockholders of record on Tuesday, August 18th were paid a $0.11 dividend. The ex-dividend date of this dividend was Tuesday, August 18th. Amrize's payout ratio is 20.28%.
Amrize Company Profile
(
Free Report)
Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.
Further Reading
Want to see what other hedge funds are holding AMRZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amrize Ltd (NYSE:AMRZ - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Amrize, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amrize wasn't on the list.
While Amrize currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.